Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis-Reference-Cited by-同舟云学术

Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis

Published:2019-09-04 Issue:9 Volume:2019 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bhatt Jayesh¹,Jahnke Nikki²,Smyth Alan R³

Affiliation:

1. Nottingham University Hospitals; Paediatric Respiratory Medicine; QMC Campus Derby Road Nottingham UK NG7 2UH

2. University of Liverpool; Department of Women's and Children's Health; Alder Hey Children's NHS Foundation Trust Eaton Road Liverpool UK L12 2AP

3. School of Medicine, University of Nottingham; Division of Child Health, Obstetrics & Gynaecology (COG); Queens Medical Centre Derby Road Nottingham UK NG7 2UH

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002009.pub7/epdf/full

Reference67 articles.

1. Evaluation of once daily tobramycin versus the traditional three times daily for the treatment of acute pulmonary exacerbations in adult cystic fibrosis patients;Al Ansari;Qatar Medical Journal,2006

2. Efficacy of once daily tobramycin for acute pulmonary exacerbations of cystic fibrosis (CF) - a microbiological perspective [abstract];Al-Ansari;Thorax,2001

3. Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients;Riethmueller;Infection,2009

4. Riethmueller J Busch A Franke P Ziebach R von Butler R Stern M Pharmacodynamic variation of intravenous antibiotic treatment with ceftazidime and tobramycin in CF-patients is equally effective [abstract] 13th International Cystic Fibrosis Congress; 2000 June 4-8; Stockholm, Sweden 2000 166

5. Riethmueller J Franke P Schroeter TW Claass A Busch A Ziebach R Optimized intravenous antibiotic treatment with ceftazidime (thrice-daily vs. continuous) and tobramycin (thrice vs. once-daily) in CF patients [abstract] Abstracts of the 24th European Cystic Fibrosis Conference; 2001 June 6-9; Vienna, Austria 2001 P192

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Necessity of Tobramycin trough Levels in Once Daily Iv-Treatment in Patients with Cystic Fibrosis;Klinische Pädiatrie;2024-01-29

2. Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence;Microbiology Spectrum;2024-01-18

3. Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients;Pharmaceuticals;2023-09-25

4. BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis;Trials;2023-03-22

5. Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy;Pediatric Pulmonology;2021-09-09